The association between changes in alternative reinforcers and short-term smoking cessation
- PMID: 24598122
- PMCID: PMC4030632
- DOI: 10.1016/j.drugalcdep.2014.02.007
The association between changes in alternative reinforcers and short-term smoking cessation
Abstract
Background: While more than 50% of smokers make a serious quit attempt each year, less than 10% quit permanently. Evidence from studies of adolescent smoking and other substances of abuse suggest that alternative reinforcers, a construct of Behavioral Economic Theory, may contribute to the likelihood of smoking cessation in adults. This study examined the behavioral economics of smoking cessation within a smoking cessation clinical trial and evaluated how depressive symptoms and behavioral economic variables are associated with smoking cessation.
Methods: A sample of 469 smokers, enrolled in an effectiveness trial that provided counseling and 8 weeks of 21 mg nicotine patches, was analyzed. Alternative reinforcers (substitute and complementary reinforcers) and depressive symptoms were examined in relation to 7-day point prevalence abstinence, verified with breath carbon monoxide, 8 weeks after the quit date.
Results: Controlling for covariates associated with cessation (nicotine dependence, age of smoking initiation, patch adherence), participants who were abstinent at week 8 showed significantly higher substitute reinforcers at all time-points, compared to those who were smoking (p's<.05). Participants who were abstinent at week 8 showed lower complementary reinforcers and depressive symptoms at all time-points, compared to those who were smoking, but significant differences were confined to week 8 (p's<.01). There was no significant interaction between alternative reinforcers and depressive symptoms across the 8 weeks on week 8 abstinence.
Conclusions: These results support continued examination of Behavioral Economic Theory in understanding adult smoking cessation in order to inform future treatments and guidelines.
Keywords: Alternative reinforcers; Behavioral economics; Depression; Smoking cessation.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Conflict of interest statement
Dr. Schnoll receives medication and placebo free of charge from Pfizer and provides consultation to Pfizer and GlaxoSmithKline.
Figures
References
-
- Abbott PJ. A review of the community reinforcement approach in the treatment of opioid dependence. J. Psychoactive Drugs. 2009;41:379–385. - PubMed
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition. Washington, DC: American Psychiatric Association; 1994.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
